| Basics |
|
Oric Pharmaceuticals, Inc.
|
| IPO Date: |
April 24, 2020 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$1.07B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.46 | 3.61%
|
| Avg Daily Range (30 D): |
$0.28 | 2.32%
|
| Avg Daily Range (90 D): |
$0.32 | 2.76%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.41M |
| Avg Daily Volume (30 D): |
1.03M |
| Avg Daily Volume (90 D): |
.99M |
| Trade Size |
| Avg Trade Size (Sh.): |
83 |
| Avg Trade Size (Sh.) (30 D): |
71 |
| Avg Trade Size (Sh.) (90 D): |
71 |
| Institutional Trades |
| Total Inst.Trades: |
928 |
| Avg Inst. Trade: |
$1.56M |
| Avg Inst. Trade (30 D): |
$1.23M |
| Avg Inst. Trade (90 D): |
$1.44M |
| Avg Inst. Trade Volume: |
.13M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.72M |
| Avg Closing Trade (30 D): |
$1.56M |
| Avg Closing Trade (90 D): |
$1.76M |
| Avg Closing Volume: |
144.01K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.33
|
$-.47
|
$-.42
|
|
Diluted EPS
|
$-.33
|
$-.47
|
$-.42
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -32.59M
|
$ -36.36M
|
$ -30.02M
|
|
Operating Income / Loss
|
$ -36.67M
|
$ -39.06M
|
$ -32.72M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -26.2M
|
$ 26.53M
|
$ -10.07M
|
|
PE Ratio
|
|
|
|
|
|
|